Fair 61°
Tag:

Emergency Use Authorization

News
NJ Company's Experimental COVID Drug Could Be Major Game-Changer NJ Company's Experimental COVID Drug Could Be Major Game-Changer
NJ Company's Experimental COVID Drug Could Be Major Game-Changer New Jersey drug manufacturer Merck & Co. and Ridgeback Biotherapeutics on Friday said the new experimental COVID-19 drug significantly reduces hospitalization time and chance of death for 50 percent of patients with mild to moderate cases. In light of the new findings, the Kenilworth-based company has stopped the drug's trial to apply for emergency use authorization. Molnupiravir is an oral pill and inhibits the replication of the virus inside of the body. “The news of the efficacy of this particular antiviral is obviously very good news,” White House chief medical advisor Dr. Ant…

SHARE

by Cecilia Levine
News
Hackensack Meridian's New Coronavirus Test Reduces Wait Time From Days To Hours Hackensack Meridian's New Coronavirus Test Reduces Wait Time From Days To Hours
Hackensack Meridian's New Coronavirus Test Reduces Wait Time From Days To Hours Hackensack Meridian Health has created a test that health officials say could save patients days of waiting for test results and help control the spread of coronavirus. Approved by the state's health department, the rapid response test will create a more effective triage system in hospitals and potentially better control the spread of coronavirus -- specifically reducing wait time from days to just hours, officials said. “We believe our test could make the difference in stemming outbreaks,” said David S. Perlin, Ph.D., the chief scientific officer and senior vice president of the …

SHARE

by Jon Craig